LONDON: China’s legal domestic market for pangolin medicine products is a key driver of the global illegal trade and poaching of pangolins, a new briefing from the London-based Environmental Investigation Agency (EIA) demonstrates. A View from the Courts – The illegal trade of pangolins in China analyses 169 Chinese court judgments involving pangolins from 2014 […]
China’s legal domestic market for pangolin medicine products is a key driver of the global illegal trade and poaching of pangolins, a new EIA briefing demonstrates. A View from the Courts – The illegal trade of pangolins in China analyses 169 Chinese court judgments involving pangolins from 2014 to June 2024, accessed through the China […]
The 78th World Health Assembly of the World Health Organization (WHO) has adopted the global traditional medicine strategy 2025-34 which sets out guiding principles, strategic objectives, directives and actions for WHO, its member states and other stakeholders to support the development of traditional, complementary and integrative medicine (TCIM). While TCIM plays an important role in […]
On 25 March, the National Medical Products Administration of China announced the release of the 2025 edition of the Chinese Pharmacopeia, to be implemented from 1 October this year. The release generated much fanfare because this latest edition removed 13 formulae which include pangolin in the ingredients. Sounds good! But don’t be fooled by the […]
The Government of China has made a commitment (Chinese) to supporting the development of substitutes for endangered wildlife used in traditional Chinese medicine (TCM). The announcement by the National Medical Products Administration of China (NMPA) is an encouraging step towards ending the use of threatened wildlife in TCM and represents tangible progress following a proposal […]
Norges Bank has divested from a major traditional Chinese medicine (TCM) company in the wake of EIA’s major exposé Investing in Extinction, which found the body parts of threatened leopards and pangolins being used as ingredients in at least 88 products. The bank cited an ‘unacceptable risk’ of Tianjin Pharmaceutical Da Re Tang Group Corp […]